Chapter 6

Valuation

At $669, Meta trades at 28.5x reported earnings, but a one-time tax charge distorts that: the trailing multiple is 22.5x normalized and near 20x forward, the low end of the mega-cap cohort. The deep discount a value buyer would have found in late 2022 is gone; the fallen star has already re-rated. The margin of safety now sits in the durability of the earnings, not in the price.

What $669 buys

The starting arithmetic is unambiguous. Meta closed the most recent session at $669.21, and on 2.57 billion diluted shares that is a market capitalization of roughly $1.72 trillion. The company carries about $22.8 billion of net cash — $35.9 billion of cash plus $45.7 billion of marketable securities against $58.7 billion of long-term debt [1] — so enterprise value is about $1.70 trillion, barely below the equity value. Net cash is small enough, relative to size, that Meta is valued almost entirely on the earnings power of the operating business, not on its balance sheet.

Sources: current market price and share count per market data, as reported; balance-sheet cash, securities and debt from the FY2025 10-K [2].

What that $1.70 trillion of enterprise value is asked to earn against depends heavily on which line of the income statement is used — and the lines diverge more than usual this year.

The tax charge and the real multiple

Reported 2025 net income was $60.46 billion, and diluted EPS was $23.49 [3]. At $669, that is a trailing price-to-earnings multiple of 28.5x. But 2025 earnings absorbed a single non-cash charge that has nothing to do with the operating business: a $15.93 billion income-tax charge recorded in the third quarter — $14.03 billion of it a valuation allowance — triggered by the One Big Beautiful Bill Act interacting with the Corporate Alternative Minimum Tax [4]. Add it back and normalized net income is about $76.4 billion, or roughly $29.68 a share — a 22.5x multiple. Management has guided the 2026 tax rate back to 13–16% [5], so the normalized figure, not the reported one, is the fair basis for a forward comparison.

The same $669 price therefore carries six defensible multiples, and the spread between them is the whole valuation debate in one picture.

Sources: multiples derived from the FY2025 10-K income statement [6], cash-flow statement [7] and the tax-charge disclosure [8]; consensus forward EPS per market data.

On earnings-based lenses — EV/EBITDA of 16.7x, normalized 22.5x, forward 20.4x — Meta is priced like a large, profitable, moderately-growing business, not a speculation. On the cash-based lens it looks dear: at $46.1 billion of free cash flow ($115.8 billion of operating cash flow less $69.7 billion of capital expenditure [9]), the price-to-free-cash-flow multiple is 37x and the free-cash-flow yield is 2.7%. That gap between a 15x cash-flow multiple and a 37x free-cash-flow multiple is not noise. It is the capital-expenditure build (AI and Reality Labs) sitting between operating cash and free cash, and it is the single largest reason two careful analysts could reach opposite conclusions about whether the stock is cheap.

The fallen star has already re-rated

For a buyer drawn to companies the market has given up on, the relevant fact is that Meta's cheap moment has passed. The multiple compressed to a genuine trough in November 2022, when the shares changed hands near $89 against trailing earnings of $8.59 — roughly 10x, and less than 3x on an ex-Reality-Labs basis. That was the fallen-star window. Since then the stock has re-rated most of the way back: the year-end trailing multiple has climbed from 14x in 2022 to 28x now, and it currently sits above its own five-year average and only modestly below the ~34x it briefly reached at the 2025 high.

Source: derived from reported diluted EPS in the FY2021–FY2025 10-Ks [10] and year-end share prices per market data. The November-2022 intraday trough was near 10x.

The read for a value discipline is that the pessimism which made Meta a screaming buy in 2022 is no longer in the price. At 20x forward and 28x trailing, the market is not hating this company; it is paying a normal-to-full multiple for a franchise it now respects. The residual discount that remains — Meta trades cheaper than most of its mega-cap peers, at roughly 20–22x forward against Amazon near 30x and Nvidia in the mid-20s — reflects a specific worry the peers share to a lesser degree: that tens of billions of dollars of annual reinvestment may not earn its cost.

Where the multiple splits: cash today, earnings tomorrow

The forward case for the stock rests on EPS that consensus puts at $32.84 for 2026 and $34.99 for 2027, against $253 billion and $302 billion of revenue. Taken at face value, $32.84 is 40% above 2025's reported $23.49, and 20x forward earnings growing 40% looks inexpensive. But most of that headline jump is the tax charge reversing, not operating growth: measured against normalized 2025 earnings of about $29.68, consensus 2026 EPS growth is roughly 11%, even as revenue is expected to grow about 26%. The wedge between 26% revenue growth and 11% earnings growth is margin compression — the depreciation and infrastructure cost of the AI build landing in the P&L faster than the incremental revenue it is meant to produce (AI and Reality Labs).

Sources: consensus 2026 EPS and revenue per market data; normalized 2025 earnings derived from the FY2025 10-K after adding back the $15.93B tax charge [11].

This is what makes the free-cash-flow multiple, not the earnings multiple, the honest test. If the 2026 capital-expenditure guidance of $115–135 billion — up from $69.7 billion — is a temporary depression of free cash flow that reverses once the AI infrastructure earns its keep, then paying 20x normalized earnings for a business compounding revenue in the mid-20s is reasonable, and the 37x free-cash-flow multiple is a mirage. If instead the elevated capital intensity is the new steady state, then free cash flow is the truer measure of what owners receive, and 37x is the multiple that matters. Management's own guidance leans to the first reading — it expects 2026 operating income above 2025 [12] — but that is a statement about the income statement, where the depreciation lags, not about free cash flow, where the cash has already left.

The high-flyer test

Weighed against a discipline that excludes expensive stocks and demands a wide margin of safety, Meta lands in an awkward middle. It is not a high flyer in the cohort sense: at roughly 20x forward earnings and 17x EV/EBITDA, with net cash and $115.8 billion of operating cash flow, it is priced more conservatively than most of the companies it is grouped with, and nowhere near the multiples that define a speculative name. But it is not a margin-of-safety bargain either. The clean discount was a 2022 event; today's price embeds a normal multiple on earnings that are themselves flattered by a reinvestment cycle whose return is unproven. The valuation cushion is thin, and what cushion exists comes from the operating cash flow the advertising engine throws off (Advertising Moat), not from a low price.

Sources: FY2025 10-K income statement [13] and cash-flow statement [14]; 2026 guidance from the Q4 FY2025 earnings call [15].

One capital-return figure is worth holding alongside the multiple, because it bounds the downside a value buyer worries about most. In 2025 Meta returned about $31.6 billion to shareholders — $26.2 billion of buybacks and $5.3 billion of dividends [16] — while still funding the entire capital build from internal cash and holding net cash positive. A company that self-funds a $70 billion capital program, returns $30 billion, and carries near-zero bankruptcy risk is not where a value investor loses money permanently. The question the price poses is narrower: not whether Meta survives, but whether 20x normalized earnings leaves enough room if the reinvestment earns less than management expects.